Michael Carroll - BIOLASE Corporate Secretary

BIOLDelisted Stock  USD 0.05  0.02  27.46%   

Executive

Michael Carroll is Corporate Secretary of BIOLASE
Age 52
Phone949 361 1200
Webhttps://www.biolase.com

BIOLASE Management Efficiency

The company has return on total asset (ROA) of (0.2682) % which means that it has lost $0.2682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.0476) %, meaning that it created substantial loss on money invested by shareholders. BIOLASE's management efficiency ratios could be used to measure how well BIOLASE manages its routine affairs as well as how well it operates its assets and liabilities.
BIOLASE currently holds 17.91 M in liabilities with Debt to Equity (D/E) ratio of 1.07, which is about average as compared to similar companies. BIOLASE has a current ratio of 2.41, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about BIOLASE's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Kimberly BambachTivic Health Systems
53
Katrina JDBioventus
62
Jordan MDTandem Diabetes Care
N/A
Stacey StewartDexCom Inc
N/A
Jeff EidelPacific Biosciences of
47
Stephanie HuebnerVivos Therapeutics
N/A
John KowalczykNuwellis
N/A
Teri LawverDexCom Inc
57
Noga ShabshinNano X Imaging
N/A
Larry ChenBioventus
N/A
David EsqTandem Diabetes Care
54
Les DeLucaBluejay Diagnostics
N/A
Robert ScottNuwellis
43
Brett JDPacific Biosciences of
N/A
Orit WimpfheimerNano X Imaging
53
Ofir KorenNano X Imaging
54
Amir RippelNanoVibronix
N/A
MBA BSBioventus
N/A
Nicholas DeGennaroVivos Therapeutics
N/A
Deina WalshBone Biologics Corp
60
John BallardVivos Therapeutics
N/A
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. Biolase operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 158 people. BIOLASE (BIOL) is traded on NASDAQ Exchange in USA and employs 157 people.

Management Performance

BIOLASE Leadership Team

Elected by the shareholders, the BIOLASE's board of directors comprises two types of representatives: BIOLASE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIOLASE. The board's role is to monitor BIOLASE's management team and ensure that shareholders' interests are well served. BIOLASE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIOLASE's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Rodriguez, Director Events
Jennifer Bright, Chief Officer
Matthew Wilson, Vice President of Human Resources
John Beaver, CFO, Senior Vice President
Russell DDS, Chief Officer
Michael Carroll, Corporate Secretary
Steven Sandor, Chief Officer

BIOLASE Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIOLASE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in BIOLASE Stock

If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum